Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
I-MED Pharma
Saint-Laurent/Montreal, Quebec, Canadaimedpharma.com ↗
- Ownership
- Private
- Employees
- ~53
- Development stage
- Other
01
Overview
I-MED Pharma’s products are commercially available globally for the diagnosis and management of dry eye disease. The company has pioneered viscoadaptive artificial tears with superior hyaluronan content, IRPL® device technology for meibomian gland dysfunction, diagnostic tools like the I-PEN®, ocular hygiene cleansers such as I-LID ’N LASH®, nutritional supplements including omega‑3s, punctum plugs, ointments like I‑DEFENCE®, and therapeutic accessories. Their solutions are used by ophthalmologists, optometrists, veterinarians, and patients worldwide.[1][2][7] No clinical trial results are published; products are marketed based on innovation in formulation/device design.
- Therapeutic areas
- Ophthalmology
- Modalities
- Device (diagnostic tools such as I-PEN)Biologic (artificial tears with hyaluronan component)Small molecule (nutritional supplements like omega‑3)Non-pharmacological therapy (ocular hygiene cleansers and accessories)Polymer-based therapy (viscoadaptive artificial tears)
- Industry
- Metabolite Diagnostics
02
Partnerships
none specifically disclosed; works closely with global distribution partners [7]
Beyond the preview
Go deeper on I-MED Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on I-MED Pharma.